Pharmalytics
The Pharmalytics quarterly reports provide curated knowledge and in-depth market insights into key trends, ecosystem strategies, and innovations shaping the global pharmaceutical logistics landscape. Designed for industry leaders and decision-makers, our Pharma.Aero exclusive reports deliver actionable intelligence to help you navigate a rapidly evolving market and make informed strategic choices.
New release: Q1 2026 edition headlines
Pharma.Aero members, read the full exclusive report in the Member Area of our website here.
-
Column | Resilience must not become the next buzzword
Editorial Column by Frank Van Gelder
- Rewiring global pharmaceutical trade | How geopolitics, supply chain resilience, and strategic control are reshaping a $900 billion global market in 2025-2026.
-
Pharma market developments | Focus on the global generic medicines sector: from globalisation to market dependency, what are the future trajectories?
- Pharma & Life Sciences Logistics Markets Q1 2026: Local Mergers, Global Investments and Geopolitical Shifts
Previous Editions
Pharma.Aero members, read the full exclusive report in the Member Area of our website here
Pharmalytics - Q4, 2025 Exclusive Report
Pharmalytics - Q3, 2025 Exclusive Report
Pharmalytics - Q2, 2025 Exclusive Report
Pharmalytics - Q1, 2025 Exclusive Report
Pharmalytics - Q4, 2024 Exclusive Report
Pharmalytics - Q3, 2024 Exclusive Report
Pharmalytics – Q4, 2025 Exclusive Report
- Editorial Column by Prof. Dr. Wouter Dewulf: From “Move Boxes” to “Move Outcomes” Why Pharma Logistics must grow up, fast!
- Pharma Logistics Data: Impact of the current U.S. – China Trade War on the U.S. Imports of Pharmaceuticals and APIs
- Pharma & Life Sciences Logistics Trends: The Supersonic Speed of Medical Innovations – The Transformative Impact on Pharmaceutical Logistics
- Pharma & Life Sciences Logistics Markets: The most strategically significant developments of Q4 2025
Pharmalytics – Q3, 2025 Exclusive Report
- Editorial Column: From Grand Cru to Prosecco, the Next Chapter for Pharma Logistics
- Data & Market Insights: Japan’s Healthcare Market
- Industry News: Pharma & Life Sciences Logistics Markets – Q3 2025
- Logistics Trends: The Evolution of AI Integration in Pharmaceutical R&D and the Changing Clinical Trial Landscape from Hospital to At-Home
Pharmalytics – Q2, 2025 Exclusive Report
- Editorial Column: Training Needs in Pharma Logistics
- Data & Market Insights: The Pharma E-commerce Market – Covers digital disruption in pharmaceutical sales and delivery, key players (Amazon, JD.com), growth projections, and regulatory challenges.
- Industry News: Pharma & Life Sciences Logistics Markets – Q2 2025
- Logistics Trends: Radiopharmaceuticals & Precision Logistics
Pharmalytics – Q1, 2025 Exclusive Report
- Global trade and erosion of predictability: A pharmaceutical perspective
- From antibiotics to hormones: A deep dive into the EU’s pharmaceutical ingredient imports
- Mapping global veterinary vaccine trade: Major exporters, importers, and future trends
- Breaking the cold chain: How thermostable technologies are transforming vaccine stability and global logistics
- Pharma & Life Sciences Logistics Markets Q1 2025: Regional mergers, bold integrator moves, and a strategic redirection of supply chains away from geopolitical risk zones
Pharmalytics – Q4, 2024 Exclusive Report
-
In-Depth Analysis of Europe’s Pharmaceutical Export Growth, Trade Flows, and Key Market Subcategories
-
Key Developments in Pharma Logistics for 2024: Mergers, Technological Advancements, and Geopolitical Impact
-
Disrupting Healthcare: The Digital-to-Consumer Shift and the Role of Smart Hospitals in Advancing Medtech and Pharma Innovation
Pharmalytics – Q3, 2024 Exclusive Report
-
Data & analytics on global product flows through major airports and maritime ports
-
Key insights on supply chain trends, including sustainability, innovation, and regulatory shifts
-
Updates on new product designs and their impact on logistics
-
A detailed overview of ecosystem developments, including partnerships, digital transformation, and CSR